CRL Charles River Laboratories International, Inc.
Platform & Compounding FCF
C- 45.8 / 100 composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

Profitability

Weight: 25%
D- 32
  • 5yr Avg ROIC 6.8%
  • Operating Margin Trend -1.88 pp/yr

Capital Efficiency

Weight: 15%
C+ 59
  • 5yr Avg ROE 7.7%
  • 5yr Share-Count CAGR -0.9%

Growth Quality

Weight: 25%
D- 33
  • 5yr Revenue CAGR 3.2%
  • 5yr EPS CAGR -70.3%
  • Revenue-Growth Years (5) 3/5

Cash Generation

Weight: 20%
B 70
  • 5yr FCF Margin 11.3%
  • 5yr FCF/NI Conversion 12.86x

Balance Sheet

Weight: 10%
C- 50
  • Net Debt / EBITDA 3.13x
  • Interest Coverage (EBIT/Int) 4.74x
  • Altman Z-Score 2.00

Stability

Weight: 5%
D 39
  • EPS Volatility (σ/μ) 0.59
  • Piotroski F-Score 4
  • Negative-Revenue Years (5) 2/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Dumping

3 of 5 gurus held; 1 added; 2 trimmed; 2 full exits.

Holders
3 -2
Avg Δ position
-33.4%
New buys
0
Full exits
2
As of Q1 2026